Imaging the Uterine Cervix - UltraSightHD™

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate the performance ability of the UltraSightHD™. The instrument will be assessed on characteristics such as focus quality, ability to image the entire cervix, and illumination. The information gathered from this study will provide data that will be used to determine which settings provide the best imaging outcome for the cervix for a simple screening instrument. Further, this information will serve as the foundation in the development of more advanced follow-on imaging devices.

The primary objectives of this study are to:

- Determine if the light source provides sufficient illumination of the cervix.

- Assess focus and overall image quality.

- Assess the functionality and ergonomics of the instrument's design.

Clinical Trial Description

n/a

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Uterine Cervical Neoplasms

Clinical Trial Details

NCT number	NCT01090635
Study type	Observational
Source	STI-Medical Systems
Contact
Status	Completed
Phase	N/A
Start date	March 2010
Completion date	February 2011

View Details

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT03225443` - Observation and Evaluation of Short-term Curative Effect of Local Advanced Cervical Cancer Treated With Particle Radiotherapy Versus Neoadjuvant Chemotherapy	N/A
Recruiting	`NCT01373723` - Economic Evaluation of Three Populational Screening Strategies for Cervical Cancer	N/A
Terminated	`NCT01234480` - Intended Use Study of the BD SurePath Plus™ Pap
Completed	`NCT02808832` - An HPV Vaccine Provider Intervention in Safety Net Clinics	N/A
Terminated	`NCT01194609` - A Pilot Study of Radiation-Immune Cell Combination Therapy in Cervical Cancer	Phase 1/Phase 2
Completed	`NCT01014026` - Self-sampling and Human Papillomavirus (HPV)-Testing for Unscreened Women in Cervical Cancer Prevention	Phase 3
Terminated	`NCT01075412` - FLT PET Imaging for Cervical Cancer	Phase 2
Completed	`NCT02865889` - Cost-Effectiveness and Patients Satisfaction of Conventional vs Robotic-Assisted Laparoscopy in Gynecologic Oncologic Indications	N/A
Completed	`NCT00377845` - Cervix Cytological Screening - Comparison of Tampon Self-Test and the Routine Smear.	Phase 0
Recruiting	`NCT05531981` - Detection of Minimal Residual Disease Based on HPV ctDNA in Cervical Cancer
Recruiting	`NCT05393440` - First-in-human (FIH) Phase I Trial of BS-006 in Cervical Cancer	Phase 1
Recruiting	`NCT05007106` - MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)	Phase 2
Completed	`NCT02866006` - Safety and Tolerability Evaluation Study of BVAC-C in Patients With HPV Type 16 or 18 Positive Cervical Cancer	Phase 1/Phase 2
Completed	`NCT02320578` - 2D Versus 3D Radical Laparoscopic Hysterectomy for Cervical Cancer: a Prospective Randomized Trial	N/A
Completed	`NCT03270995` - Cognitive-Existential Group Therapy to Reduce Fear of Cancer Recurrence: A RCT Study	N/A
Terminated	`NCT02900248` - CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Not yet recruiting	`NCT05065853` - Urinary and Vaginal HPV Testing in Cervical Cancer Screening
Completed	`NCT01231945` - Low-Cost Molecular Cervical Cancer Screening Study	N/A
Completed	`NCT01717391` - [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers	Phase 2
Active, not recruiting	`NCT04947605` - Epidemiological Landscape of Cervical Cancer in Latin America